Medicare Enrolled
Dr. James Kay, M.D.
Optician · Evans, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kay?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kay
Dr. James Kay is an optician specialist in Evans, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kay performed 9,974 Medicare services across 3,047 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kay received a total of $4,474 from 40 pharmaceutical and/or device companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in GA
$4,474 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,974
Medicare services
Top 3% in GA for optician
3,047
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~525 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,200 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,098 | $58 | $162 |
| Leuprolide injectable, camcevi, 1 mg | 714 | $67 | $240 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
697 | $2 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
349 | $88 | $246 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
273 | $8 | $22 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
269 | $7 | $108 |
| PSA test (prostate cancer screening) | 210 | $18 | $51 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 196 | $128 | $700 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
186 | $60 | $700 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
111 | $76 | $225 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
86 | $18 | $51 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $110 | $359 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
50 | $23 | $352 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
49 | $91 | $850 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
49 | $36 | $84 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $36 | $100 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
39 | $177 | $1,045 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $23 | $125 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $10 | $100 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
31 | $19 | $51 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
26 | $58 | $225 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
23 | $316 | $2,000 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
22 | $15 | $60 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
20 | $40 | $190 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $99 | $291 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $102 | $1,400 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
17 | $75 | $600 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
14 | $10 | $275 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
12 | $99 | $950 |
| CT scan of abdomen with and without contrast A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures. |
12 | $97 | $1,060 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
57.2% medium
42.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,474
Total received (2018-2024)
Avg $639/year across 7 years
Top 25% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
193
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,432 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,235
2023
$842
2022
$883
2021
$547
2020
$192
2019
$382
2018
$393
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$275
Ferring Pharmaceuticals Inc.
$203
Sumitomo Pharma America, Inc.
$177
Teleflex LLC
$141
BIOTISSUE HOLDINGS INC.
$118
Bayer Healthcare Pharmaceuticals Inc.
$113
ABBVIE INC.
$60
PFIZER INC.
$52
Agiliti Surgical, Inc.
$41
COLOPLAST CORP
$21
Ethicon US, LLC
$18
Endo Pharmaceuticals Inc.
$15
Top 3 companies account for 53.0% of 2024 payments
All-time payments by company (2018-2024) ›
Axonics, Inc.
$975
Astellas Pharma US Inc
$829
Sumitomo Pharma America, Inc.
$266
Ferring Pharmaceuticals Inc.
$203
Boston Scientific Corporation
$172
ABBVIE INC.
$170
Janssen Biotech, Inc.
$163
Bayer Healthcare Pharmaceuticals Inc.
$146
Teleflex LLC
$141
Blue Earth Diagnostics Limited
$132
Endo Pharmaceuticals Inc.
$120
BIOTISSUE HOLDINGS INC.
$118
AbbVie Inc.
$101
UroGen Pharma, Inc.
$97
Myovant Sciences Inc.
$96
UROVANT SCIENCES INC
$81
PFIZER INC.
$68
Allergan Inc.
$65
Merck Sharp & Dohme LLC
$55
AstraZeneca Pharmaceuticals LP
$50
Antares Pharma, Inc.
$42
Agiliti Surgical, Inc.
$41
Dendreon Pharmaceuticals LLC
$35
Merck Sharp & Dohme Corporation
$32
Medtronic, Inc.
$25
Retrophin, Inc.
$25
Travere Therapeutics, Inc.
$25
Allergan, Inc.
$21
BAXTER HEALTHCARE
$21
COLOPLAST CORP
$21
Ethicon US, LLC
$18
PROCEPT BioRobotics Corporation
$17
Myriad Genetic Laboratories, Inc.
$17
Coloplast Corp
$16
MEDIVATION FIELD SOLUTIONS LLC
$14
Cardinal Health 414 LLC
$14
Supernus Pharmaceuticals, Inc.
$13
Mission Pharmacal Company
$11
AbbVie, Inc.
$11
Ambu Inc.
$10
Top 3 companies account for 46.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AVEED · AquaBeam Robotic System · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · ERLEADA · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · General - Kidney Stone Disease · Harmonic · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE EMPOWER · LUPRON DEPOT · LYNPARZA · Luja Coude · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · PROVENGE · Prolaris · Sonablate HIFU · TISSEEL · Thiola · Titan · Uribel · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
61
Per 100K population
38.2
County median income
$96,122
Nearest hospital
DOCTORS HOSPITAL
7.9 mi
7.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kay is a clinical cardiology specialist, with above-average Medicare volume (top 3% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kay experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kay performed 5,200 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kay receive payments from pharmaceutical companies?
Yes. Dr. Kay received a total of $4,474 from 40 companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kay's costs compare to other opticians in Evans?
Dr. Kay's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Evans
Browse opticians in Evans ranked by procedure volume and transparency data.
Highest volume
Top Opticians in GA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in GA
Which GA opticians receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology